10/16/2026
In case you missed it! Pangea Pharmaceuticals recently announced the U.S. launch of Sdamlo™, the first and only FDA-approved amlodipine powder for oral solution!
This milestone reflects our commitment to advancing patient-centered pharmaceutical innovation and providing alternative dosage forms to meet diverse patient needs.
🔗 Read more: https://www.pangeapharm.com/pharmaceuticals/pangea-pharmaceuticals-announces-u-s-launch-of-sdamlo-the-first-and-only-fda-approved-amlodipine-powder-for-oral-solution/
Specialty Pharmaceutical Company